Streetbeat News

Analyst Ratings

SPB

Spectrum Brands Holdings, Inc. (NYSE:SPB) is expected to report lower Q3 earnings for fiscal 2023, with analysts predicting earnings of 40 cents per share, down from 54 cents per share in the previous year. The company's revenue is also expected to decrease to $787.11 million from $818 million. Spectrum Brands shares fell 0.3% to close at $75.11 on Thursday. Recent analyst ratings include Wells Fargo's Overweight rating with a price target of $90, Oppenheimer's Outperform rating with a price target of $82, and Deutsche Bank's Hold rating with a price target of $70.

Portfolio Pulse from Lisa Levin

August 11, 2023 | 6:13 am

SSIC

Silver Spike Investment (NASDAQ:SSIC) reported Q2 NII of $0.31 per share, beating the analyst consensus estimate of $0.22 by 40.91%. This is a 244.44% increase from the same period last year. The company also reported quarterly sales of $2.89 million, beating the analyst consensus estimate of $2.61 million by 10.88%. This is a 145.05% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 5:48 am

RIVN

TSLA

Wedbush Analyst Dan Ives views Rivian (NASDAQ:RIVN) as a core EV player over the next decade. Rivian's Q2 performance saw a 50% increase in vehicle deliveries from the previous quarter, surpassing expectations. The company is refining its manufacturing processes and introducing in-house components to cut production costs. Despite a recent 16% drop, Rivian's stock remains 25% up in 2023.

Portfolio Pulse from Benzinga Neuro

August 11, 2023 | 2:50 am

BTCUSD

DOGEUSD

ETHUSD

Major cryptocurrencies showed resilience amid the release of Consumer Price Index (CPI) data. Bitcoin, Ethereum, and Dogecoin experienced mixed trading, with Bitcoin and Ethereum slightly down and Dogecoin slightly up. The global crypto market capitalization stands at $1.17 trillion, a 0.48% decrease in the last day. Analysts predict that Bitcoin could reach over $70,000 this year, despite its struggle to maintain a consistent price above $30,000 in recent months.

Portfolio Pulse from Mehab Qureshi

August 11, 2023 | 2:38 am

VRCA

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) has presented lesion clearance data from an ongoing Phase 2 study of VP-315 for the treatment of basal cell carcinoma (BCC) at the American Academy of Dermatology 2023 Innovation Academy Meeting. The data shows the antitumor response of VP-315 as determined by clinical and histological clearance of treated BCC lesions. The company reported that 67% of subjects showed complete tumor clearance. The company plans to expand Part 2 of the ongoing Phase 2 trial which will accelerate the clinical development of VP-315.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 9:22 pm

BIOL

Biolase (NASDAQ:BIOL) reported Q2 losses of $(4.24) per share, beating the analyst consensus estimate of $(5.33) by 20.45 percent. However, the company's quarterly sales of $14.29 million missed the analyst consensus estimate of $15.36 million by 6.99 percent.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 9:02 pm

AAPL

APP

Analysts have mixed sentiments about AppLovin Corp (APP) due to the promising growth of AXON 2.0 and potential challenges from Apple. Benchmark analyst Mark Zgutowicz maintained a Sell rating but raised the price target from $17 to $22. Wedbush analyst Nick McKay maintained an Outperform rating and raised the price target from $37 to $48. Credit Suisse analyst Stephen Ju also maintained an Outperform rating and raised the price target from $49 to $57. APP shares closed higher by 26.50% to $37.20 on Thursday.

Portfolio Pulse from Anusuya Lahiri

August 10, 2023 | 9:01 pm

GDRX

Over the last quarter, 13 analysts have provided ratings for GoodRx Holdings (NASDAQ:GDRX), with 3 being bullish, 1 somewhat bullish, and 9 indifferent. The average 12-month price target for the company is $8.58, a 34.06% increase from the previous average of $6.40.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 9:00 pm

DAR

Over the past 3 months, 9 analysts have published their opinion on Darling Ingredients (NYSE:DAR) stock. The average price target is $81.78, implying an upside from the current price of $63.65. However, this average has decreased by 10.13% from the previous average price target of $91.00.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 9:00 pm

VVV

Over the past 3 months, 5 analysts have published their opinion on Valvoline (NYSE:VVV) stock. The average price target is $39.2, implying an upside from the current price of $34.44. The current average has decreased by 2.8% from the previous average price target of $40.33.

Portfolio Pulse from Benzinga Insights

August 10, 2023 | 9:00 pm